https://www.pharmaceutical-technology.com/news/krystal-biotech-gene-therapy/ 2023-05-29T05:36:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/pharma-ma-resurge-late-2023/ 2023-05-26T13:36:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/fda-approval-rinvoq-crohns-disease/ 2023-05-26T13:25:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/daiichi-japans-approval-vanflyta/ 2023-05-26T13:19:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-review-takeda-hutchmeds-fruquintinib/ 2023-05-29T04:09:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/hanall-biopharma-daewoong-parkinsons/ 2023-05-26T08:52:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/applied-therapeutics-ema-orphan/ 2023-05-26T08:38:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ema-sandoz-marketing-denosumab/ 2023-05-26T08:38:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/the-us-debt-ceiling-crisis-the-ultimate-gift-for-china/ 2023-05-25T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-agency-pilots-biobank-to-study-links-between-genetics-and-drug-side-effects/ 2023-05-25T17:09:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/transgene-and-bioinvent-report-positive-data-for-oncolytic-virus/ 2023-05-25T17:00:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/meningitis-vaccine-comes-to-the-forefront-with-impressive-study-results/ 2023-06-30T06:01:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-delays-sareptas-dmd-gene-therapy-decision-until-june/ 2023-05-26T04:53:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/medicines-adherence-overcoming-pharmas-biggest-barrier-to-treatment-success/ 2023-05-25T16:25:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/adalvo-eql-pharma-mellozzan/ 2023-05-25T14:05:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pyxis-oncology-buy-apexigen/ 2023-05-25T13:53:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/celltrion-yuflyma-fda-approval/ 2023-05-25T10:24:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/elevatebio-cell-gene-therapies/ 2023-06-01T09:06:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/appili-us-patent-ati-1501/ 2023-05-25T07:43:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/clover-kyuan-trade-adimflu-s-qis/ 2023-05-25T09:13:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/the-fdi-landscape-in-panama-in-2023/ 2023-05-24T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-government-plans-proposal-to-push-down-medicaid-drug-prices/ 2023-05-24T18:51:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-greenlights-new-long-term-treatment-option-for-opioid-use-disorder/ 2023-05-24T16:25:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-breakthrough-pneumonia-therapy/ 2023-05-24T15:34:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nona-biosciences-modex-antibodies/ 2023-05-24T13:31:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cohbar-morphogenesis-immuno-oncology/ 2023-06-21T05:08:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/inovio-ino-3107-orphan-drug/ 2023-05-24T12:44:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/y-mabs-danyelza-injection-marketing/ 2023-05-24T10:19:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/forge-biologics-bgtc-gene/ 2023-06-01T09:06:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/novo-nordisk-wegovy-starter-doses/ 2023-05-24T08:36:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/china-junshi-tnbc-therapy/ 2023-05-24T08:10:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/rocket-gene-fda-rmat/ 2023-05-24T08:10:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovators-tetrapeptide-derivatives-pharmaceutical/ 2023-05-24T07:10:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovators-recombinant-viral-vector-based-medicinal-preparations-pharmaceutical/ 2024-07-31T06:56:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/patents/patent-activity-environmentalsustainability-pharmaceutical-industry/ 2024-10-25T03:29:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/renagade-therapeutics-enters-rna-therapy-arena-with-300m/ 2023-05-23T17:49:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/centessas-haemophilia-therapy-wins-fda-fast-track-designation/ 2023-05-23T17:47:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/quanta-raises-more-than-50-million-for-kras-inhibitor-research/ 2023-05-23T17:43:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/the-power-of-joint-procurement-analysing-cross-border-initiatives-in-benelux-and-the-nordics/ 2024-01-29T16:49:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/ecs-proposed-pharma-reforms/ 2023-05-23T16:16:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-blueprint-medicines-ayvakit/ 2023-06-07T04:42:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mhra-marketing-akebia-vafseo/ 2023-05-23T13:44:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-indivior-opvee-nasal-spray/ 2023-05-23T13:33:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/croda-pharma-bsi-qs-21/ 2023-05-23T10:17:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/clinical-trials-in-ukraine-ensuring-supply-chain-continuity-during-war/ 2025-07-16T10:56:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/avrobio-sell-cystinosis-gene-therapy/ 2023-05-23T10:18:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/alzecure-acd856-european-patent/ 2023-05-23T07:44:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biocryst-marketing-authorisation-orladeyo/ 2023-05-23T09:00:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/curevac-gets-an-early-date-in-covid-19-vaccine-patent-case-with-pfizer-biontech/ 2023-05-22T19:49:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-takes-measures-to-tackle-utrogestan-hormone-replacement-shortage/ 2023-05-22T19:05:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/intercept-suffers-setback-with-negative-adcom-decision-for-nash-therapy/ 2023-05-22T18:44:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nmpa-ind-sinomab-bioscience/ 2023-05-22T14:04:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ironwood-agrees-buy-vectivbio/ 2023-09-12T04:06:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/readmission-on-the-horizon-how-eu-funding-can-boost-british-biotech/ 2023-05-22T13:39:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-krystal-biotech-vyjuvek/ 2023-05-22T13:35:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-39m-fund-amr-research/ 2023-05-22T12:42:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/thermo-fisher-sterile-drug/ 2023-05-22T10:52:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-abbvie-genmab-epkinly/ 2023-05-22T10:42:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biogen-eisai-marketing-lecanemab/ 2023-05-22T07:28:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ema-sobi-efanesoctocog-alfa/ 2023-05-22T08:44:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ireland-ranked-as-best-country-in-which-to-start-a-business-in-2023/ 2023-05-21T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/treatment-options-for-crohns-disease-expand-after-rinvoq-approval/ 2023-07-04T05:21:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/supreme-court-backs-sanofi-in-high-profile-cholesterol-drug-suit-with-amgen/ 2023-05-19T15:35:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/oncology-biosimilar-rituximab/ 2023-05-19T15:00:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/oncoresponse-cprit-advance-or502/ 2023-05-19T14:56:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/siteone-non-opioid-therapy/ 2023-05-19T14:46:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/alimera-sciences-eyepoint-yutiq/ 2023-05-19T14:30:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-bausch-lomb-novaliqs-miebo/ 2023-05-19T14:22:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/multiple-sclerosis-dmts-cost-us/ 2023-05-19T12:56:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-fda-satsumas-505b2-nda/ 2023-05-19T10:23:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/myeloid-cell-therapy-programme/ 2023-05-19T10:30:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/sun-rises-on-lithuanias-life-sciences-industry/ 2023-05-19T14:24:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/immunoforge-agreement-duke-university/ 2023-05-19T08:31:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nice-astrazenecas-dapagliflozin-heart-failure/ 2023-05-19T08:32:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/jobs/socialresponsibility-hiring-pharmaceutical-industry/ 2023-08-03T05:22:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/parliamentarians-call-on-g7-leaders-to-invest-in-neglected-tropical-diseases/ 2023-05-23T04:23:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ema-issues-guidance-amidst-european-medicine-shortage/ 2023-05-26T23:52:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gate-neurosciences-plans-phase-ii-mdd-trial-with-next-gen-antidepressant/ 2023-05-19T15:59:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/iavi-biofabri-tb-vaccine/ 2023-05-19T15:59:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/virtual-clinical-trials-how-digital-tech-has-improved-clinical-trial-accrual-rates/ 2023-09-19T14:49:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-ardelyx-nda-xphozah/ 2023-05-19T16:00:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lapix-us-patent-lpx-ti641/ 2023-05-19T16:00:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/forbion-european-acquisition-engene/ 2023-05-19T16:00:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lumen-bioscience-lmn-201-fast-track/ 2023-05-19T16:00:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/elevar-uhcc-combo-therapy/ 2023-05-19T16:00:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ksq-takeda-tumour-intrinsic-targets/ 2023-05-19T16:00:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/beigene-brukinsa-poor-countries/ 2023-05-19T16:00:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-cities-call-devolved-powers-help-reach-net-zero-targets/ 2023-05-17T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/where-are-the-global-islamic-finance-hubs/ 2023-05-17T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/intercept-receives-orphan-drug-designation-for-liver-disease-combo-therapy/ 2023-05-29T05:32:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/inflation-reduction-act-panel/ 2023-05-17T14:55:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/chinook-ionis-aso-therapy/ 2023-05-17T13:34:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-priority-review-takeda-cttp/ 2023-05-17T13:27:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/agc-biologics-viral-vector/ 2023-05-17T12:34:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mif-nectin/ 2023-05-17T12:19:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/cell-culture-qa-solving-biomanufacturing-challenges-with-recombinant-insulin-supplementation/ 2023-05-24T08:34:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/scribe-prevail-crispr-medicines/ 2023-05-30T13:06:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/kamada-glassia-marketing-swissmedic/ 2023-05-17T10:21:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/boundless-bio-ecdna-therapies/ 2023-05-17T09:01:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/wuxi-biologics-inflarx-gohibic/ 2023-05-17T09:00:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/indian-state-of-tamil-nadu-attracts-4bn-in-new-investment/ 2023-05-16T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/how-businesses-and-investors-can-survive-a-recession/ 2023-05-16T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/research-consortium-picks-eight-rare-diseases-to-advance-gene-therapies/ 2023-05-17T16:18:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/market-cap-downturn-q1-2023/ 2023-05-16T16:02:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uniqure-sells-part-of-hemgenix-royalty-rights-in-deal-worth-up-to-400-million/ 2023-05-16T16:33:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bavarian-nordic-completes-travel-vaccine-deal-with-emergent/ 2023-05-16T15:13:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/byondis-crl-fda-syd985-bla/ 2023-05-16T14:40:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/charm-oncology-drug-discovery/ 2023-05-16T13:58:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/juno-pharmaceuticals-omega-laboratories/ 2023-05-16T12:54:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nuvectis-pharma-fda-nxp900/ 2023-05-16T12:40:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gilead-arcus-inflammatory-diseases/ 2023-05-16T10:41:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-cumberland-fever-pain/ 2023-05-16T10:42:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/immpact-bio-impt-314-fda/ 2023-06-02T04:08:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/health-canada-eisai-biogen/ 2023-05-16T08:50:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/reshoring-trend-automation-labour-cost-companies-fdi/ 2023-05-15T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/turkish-lira-could-collapse-if-erdogan-wins-run-off-election/ 2023-05-15T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astellas-nonhormonal-hot-flashes-treatment-veozah-wins-fda-nod/ 2023-05-15T17:20:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/rona-keymed-sirna-glomerulonephritis/ 2023-05-17T16:19:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-adcom-votes-in-favour-of-first-gene-transfer-therapy-for-dmd/ 2023-07-04T05:26:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nuclidium-pharmalogic-theranostics-us/ 2023-05-15T15:17:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/the-urgent-need-for-disruptive-concepts-in-the-autoinjectors-market/ 2023-06-14T13:07:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/dualyx-therapies-autoimmune-diseases/ 2023-05-15T14:31:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-and-astrazenecas-rsv-antibody-shows-mettle-in-real-world-results/ 2023-05-15T17:14:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-sisaf-sirna-ado2/ 2023-05-17T16:19:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovators-small-molecules-quinoline-derivatives-as-anticancer-agents-pharmaceutical/ 2023-05-15T11:16:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovators-peptide-nano-particle-conjugates-pharmaceutical/ 2023-05-15T11:04:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovators-peptide-based-inhibitors-for-cancer-treatment-pharmaceutical/ 2023-05-17T07:03:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovators-immuno-oncology-oncolytic-viral-proteins-pharmaceutical/ 2024-07-30T11:11:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovators-pancreatic-extract-based-compositions-pharmaceutical/ 2023-05-15T10:54:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovators-oxazole-derivatives-based-cancer-drug-compositions-pharmaceutical/ 2023-05-16T06:10:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovators-nucleoside-chemical-synthesis-pharmaceutical/ 2023-05-15T10:46:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovators-lps-antibody-based-anti-bacterials-pharmaceutical/ 2023-05-15T10:39:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovators-knockin-type-transgenic-animals-pharmaceutical/ 2024-08-29T04:19:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/singapore-authorisation-novavax-covid-19/ 2023-05-15T10:37:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovators-immunotherapy-t-cell-receptor-peptides-pharmaceutical/ 2023-05-15T10:22:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/roche-her2-drug-blood-brain-barrier/ 2023-05-15T10:15:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/aligos-amoytop-liver-diseases/ 2023-05-15T10:22:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovators-genetically-modified-t-cells-pharmaceutical/ 2024-07-29T06:59:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovators-cyclosporin-derivatives-pharmaceutical/ 2023-05-15T10:03:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovators-cyclodextrin-drug-conjugates-pharmaceutical/ 2024-08-29T03:42:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovators-attenuated-virus-based-vaccines-pharmaceutical/ 2024-08-29T04:24:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovators-anti-sense-nucleotide-based-compositions-pharmaceutical/ 2023-05-15T09:37:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/innovent-crc-therapy-breakthrough/ 2023-05-15T08:36:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lanova-medicines-astrazeneca-lm-305/ 2023-05-15T07:39:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/eisai-adc-golden-rush/ 2023-05-16T16:04:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biontech-shelves-oral-mrna-vaccine-plans-with-matinas/ 2023-05-17T16:20:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-updates-stimulant-labelling-requirements-to-reduce-misuse/ 2023-05-12T16:00:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/editas-continues-to-trend-efficacy-signals-with-sickle-cell-disease-gene-therapy/ 2023-08-30T10:04:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/researchers-crispr-drug-candidate/ 2023-05-12T14:25:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/absci-kennedy-institute-immunotherapies/ 2023-05-12T14:14:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/icr-royal-marsden-nhs/ 2023-05-12T12:48:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nybc-50m-cellular-therapy/ 2023-05-12T12:29:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/the-legal-uk-cannabis-industry-could-create-100000-new-jobs/ 2024-03-20T03:34:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/serb-pharmaceuticals-bentracimab-sfj/ 2023-05-12T10:47:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/icmr-ayush-ministry-medicine/ 2023-05-12T09:53:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/angelini-pharma-jcr-epilepsy/ 2023-05-31T04:51:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/takeda-12-8-rise-fy2022-revenue/ 2023-05-12T08:34:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/influencers-dashboards/social-media-posts-artificial-intelligence-pharma-industry/ 2023-06-20T08:54:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/influencers-dashboards/social-media-posts-covid-19-pharma-industry/ 2023-06-16T11:33:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/influencers-dashboards/social-media-posts-internet-of-things-pharma-industry/ 2023-06-16T11:33:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/what-impact-could-turkeys-election-have-on-its-fdi-inflows/ 2023-05-11T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/erdogan-earthquakes-and-turkeys-rise-and-fall/ 2023-05-11T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biontechs-rna-vaccine-sparks-potential-in-pancreatic-cancer/ 2023-06-27T16:06:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/european-regulators-revoke-covid-19-business-continuity-status/ 2023-05-11T16:50:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-adcom-votes-unanimously-in-favour-of-otc-oral-contraceptive/ 2023-05-11T16:44:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ariceum-ucb-therapies-cancer/ 2023-05-11T13:58:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/otsuka-lundbecks-rexulti-fda/ 2023-05-11T13:35:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/aviko-radiopharmaceuticals-bnct-cancers/ 2023-05-11T13:18:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/private-consortium-syneos-health/ 2023-05-11T13:06:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/servier-tibsovo-ec-cancer/ 2023-05-11T09:53:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-veeva-systems-quality/ 2023-05-11T10:10:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ec-astrazeneca-ultomiris-nmosd/ 2023-05-11T08:45:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bayer-bicycle-radioconjugates-oncology/ 2023-05-11T08:44:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/what-do-the-other-emirates-of-the-uae-have-to-offer-foreign-investors/ 2023-05-10T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/amgen-enlists-tscans-target-discovery-platform-for-crohns-disease/ 2023-07-04T05:21:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gilead-wins-patent-battle-with-us-government-over-hiv-prep-drugs/ 2023-05-10T16:24:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/first-in-class-migraine-treatment-vydura-approved-for-nhs-scotland/ 2023-05-10T16:16:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sobi-buy-cti-biopharma/ 2023-05-23T03:39:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/alvotech-polifarma-avt06-turkey/ 2023-05-10T13:21:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cytomed-md-anderson-cancer/ 2023-05-10T13:15:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/roche-zion-pharmas-zn-a-1041/ 2023-05-10T12:32:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/microparticle-analysis/ 2025-03-28T10:20:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/synlogic-synb1934-orphan-drug/ 2023-05-10T09:44:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/china-snda-therapy-nsclc/ 2023-05-10T08:56:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gilead-sciences-xinthera-oncology/ 2023-05-10T08:10:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-astrazeneca-farxiga-cv-risk/ 2023-05-10T08:25:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/artificial-intelligence-mentions-pharmaceutical-industry/ 2024-07-18T14:38:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/covid-19-mentions-pharmaceutical-industry/ 2024-07-18T14:38:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cybersecurity-mentions-pharmaceutical-industry/ 2024-07-18T14:38:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/environmental-sustainability-mentions-pharmaceutical-industry/ 2024-07-18T14:38:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/corporate-governance-mentions-pharmaceutical-industry/ 2024-07-18T14:38:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/social-responsibility-mentions-pharmaceutical-industry/ 2024-07-18T14:38:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/recursion-plans-87-5m-acquisitions-to-shore-up-ai-drug-discovery/ 2023-05-09T17:30:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/vedanta-secures-fast-track-designation-for-oral-c-diff-drug/ 2023-05-09T17:23:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eyenovia-wins-fda-approval-for-first-pupil-dilation-spray/ 2023-05-09T17:21:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/neuro3-kcnq2-activator-development/ 2023-05-09T14:43:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/laboratory-services-poised-for-the-digital-revolution/ 2023-05-09T13:29:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fibrogen-fortis-mcrpc-drug/ 2023-05-09T13:21:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/acorda-chance-inbrija-china/ 2023-05-09T12:24:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/health-canada-rhythm-imcivree/ 2023-05-09T12:15:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/statin-atrial-fibrillation/ 2023-05-09T12:01:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jiangsu-nhwa-nmpa-olinvyk/ 2023-05-09T09:57:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nmpa-koselugo-pn-nf1/ 2023-05-09T10:14:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/eli-lillys-donanemab-makes-a-splash-in-alzheimers-but-will-medicare-cover-it/ 2023-07-11T06:06:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/average-pharmaceutical-lebanon/ 2023-05-09T08:08:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/brazilian-federal-court-semaglutide-patent-extension/ 2023-05-09T07:52:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/baxter-bps-advent-warburg-pincus/ 2023-05-09T08:34:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ginkgo-boehringer-disease-therapies/ 2023-05-09T07:29:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/fentanyl-crisis-the-emergence-of-tranq/ 2023-05-09T13:33:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/the-fdi-landscape-in-kenya-in-2023/ 2023-05-08T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eisai-bliss-develop-bb-1701/ 2023-05-09T04:53:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/junshi-biosciences-dr-reddys-toripalimab/ 2023-05-08T12:44:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovators-immuno-oncology-monoclonal-antibody-conjugates-for-cancer-treatment-pharmaceutical/ 2023-05-12T13:30:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovators-zinc-finger-nucleases-pharmaceutical/ 2024-07-29T08:20:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovators-ssrna-virus-peptides-pharmaceutical/ 2023-05-08T09:45:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovators-anti-viral-antigen-based-compositions-pharmaceutical/ 2023-05-08T09:29:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovators-anti-influenza-antibody-compositions-pharmaceutical/ 2023-05-08T09:25:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovators-anti-inflammatory-anaesthetics-pharmaceutical/ 2024-09-09T05:06:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovators-oncology-gene-therapy-for-cancers-pharmaceutical/ 2023-05-08T09:58:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ec-chiesi-protalix-fabry-disease/ 2023-05-08T09:05:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovators-genetically-modified-immunosuppresants-pharmaceutical/ 2023-05-08T09:58:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovators-cytokine-activated-t-cell-based-compositions-pharmaceutical/ 2023-05-08T08:46:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovators-anti-hpv-compositions-pharmaceutical/ 2024-07-31T09:01:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/china-nmpa-beigene-brukinsa/ 2023-05-08T07:24:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/formosa-aimmax-fda-pain-therapy/ 2023-05-08T04:26:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/who-declares-end-of-covid-19-public-health-emergency/ 2023-05-05T15:07:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-raises-alarm-about-weight-gain-supplement-apetamin/ 2023-05-05T14:56:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/palobiofarma-fpwr-prader-willi-syndrome/ 2023-05-19T04:38:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/regeneron-7-rise-total-revenue/ 2023-05-05T14:23:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-negotiates-reform-for-branded-drug-payment-amidst-industry-dissatisfaction/ 2023-05-05T14:22:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/how-pharmaceutical-firms-are-making-their-supply-chains-more-efficient/ 2023-07-11T11:36:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/tff-niehs-respiratory-diseases/ 2023-05-08T13:58:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-canada-dupixent-eoe/ 2023-05-09T19:51:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/chmp-gilead-science-hepcludex/ 2023-05-05T09:39:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/siegfried-95-biotechnology-dinamiqs/ 2023-05-05T09:17:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/hasten-roche-rocephin-china/ 2023-05-05T08:59:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-optinose-snda-xhance/ 2023-05-05T07:33:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/charles-apologise-british-colonisation-fragile-monarchy-commonwealth/ 2023-05-04T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/the-impact-of-king-charles-coronation-on-the-uk-and-beyond/ 2023-05-04T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/understanding-the-current-and-future-state-of-complex-health-data-protection-laws/ 2023-12-14T12:14:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/preventing-the-spread-of-nontuberculous-mycobacteria-in-water-systems/ 2023-05-05T11:13:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-grants-gsk-first-ever-approval-for-rsv-vaccine/ 2023-05-04T13:59:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/forge-biologics-labcorp-gene-therapies/ 2023-05-10T12:52:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/arthex-biotech-dm1-therapy/ 2023-05-04T13:21:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/roche-human-model-systems/ 2023-05-04T12:52:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-fda-kamada-cytogam/ 2023-05-04T10:18:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/magenta-therapeutics-dianthus-merger/ 2023-05-04T09:34:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/vertex-fda-cystic-fibrosis-2/ 2023-05-04T09:45:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bristol-myers-squibb-breyanzi-lbcl/ 2023-05-04T08:46:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/idorsia-quviviq-health-canada/ 2023-05-04T07:27:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/secondary-cities-are-africas-next-big-investment-opportunity/ 2023-05-03T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/tenayas-cardiomyopathy-gene-therapy-gets-fast-track-boost/ 2023-05-03T14:52:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/brightpath-artisan-bio-cell-therapies/ 2023-05-03T13:44:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ionctura-clavius-tgf-%ce%b2-pathway/ 2023-05-03T12:12:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/tay-therapeutics-vyne-inhibitor/ 2023-05-03T12:01:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-bioprocessing-plant-south-korea/ 2023-05-03T11:03:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pharmather-fast-track-ketarx/ 2023-05-03T10:35:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/aurinia-lupkynis-swissmedic/ 2023-05-03T10:35:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/janssen-biotech-cbmg-car-t-therapies/ 2023-05-03T08:15:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/boehringer-breakthrough-designation-spesolimab/ 2023-05-03T08:14:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/pathbreakers-the-journey-of-first-generics/ 2023-07-06T16:10:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/ipas-must-adopt-the-triple-d-approach-or-risk-being-left-behind-mea/ 2023-05-02T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/hiring-activity-downward-trend-2023-globaldata/ 2023-05-02T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bms-licenses-tcr-t-immunotherapy-therapy-from-immatics/ 2023-05-02T20:50:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/memo-nabs-fast-track-designation-for-bk-polyomavirus-drug/ 2023-05-02T17:21:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/odaia-wins-25m-funding-to-boost-commercial-insights-platform-for-pharma/ 2023-05-02T15:17:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/advancing-parenteral-packaging-production-for-the-future-of-pharmaceuticals/ 2023-05-02T17:04:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/plus-therapeutics-pps-partnership-drug/ 2023-05-02T13:24:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/soligenix-silk-road-deal/ 2023-05-02T13:15:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/marker-cell-manufacturing-cellready/ 2023-05-02T12:39:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/erasca-fast-track-designation/ 2023-05-02T10:21:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/fda-euas-pfizer-biontech-moderna-covid-19-vaccines/ 2023-05-02T09:51:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/unmet-needs-immuno-oncology/ 2023-06-30T04:32:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-bristol-myers-squibb/ 2023-05-02T09:28:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/avadel-fda-lumryz-eds/ 2023-05-02T08:39:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/maze-sanofi-pompe-disease-therapy/ 2023-05-02T07:40:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fibrogen-receive-funding-commercialisation-pamrevlumab/ 2023-05-02T08:04:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/interviews/qa-as-rsv-vaccine-approvals-loom-regulators-need-to-devise-vaccination-strategies/ 2023-05-02T20:28:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/magazine-nanoparticle-drug-delivery-research-gets-a-boost/ 2023-05-01T13:32:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/chinas-nmpa-ocumensions-zerviate-nda/ 2023-05-01T12:03:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cirm-ossium-health-ossm-007/ 2023-05-01T10:30:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cartherics-licence-cth-004-shunxi/ 2023-05-01T08:53:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astellas-pharma-iveric-bio/ 2023-05-01T07:41:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/teva-medincell-fda-uzedy/ 2023-05-01T07:23:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/novo-nordisk-ozempic/ 2024-10-09T15:15:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ocugens-retinal-therapy-orphan-drug-status/ 2023-04-28T15:17:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/excellence-awards/featured-company/2022-syngene/ 2024-02-22T09:30:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/editas-grabs-orphan-drug-status-for-sickle-cell-disease-crispr-therapy/ 2023-04-28T14:53:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abbvie-9-7-fall-net-revenues/ 2023-04-28T13:58:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/generatebiomedicines-md-anderson/ 2023-04-28T13:44:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/tavros-openbench-small-molecule/ 2023-04-28T11:09:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/therini-bio-neurodegenerative-disease/ 2023-04-28T10:33:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/otsuka-lundbeck-abilify-asimtufii/ 2023-04-28T10:05:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/api-facilities-europe-drug-shortages/ 2024-11-22T11:04:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-pfizer-prevnar-20/ 2023-04-28T08:01:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/chmp-gsk-rsv-vaccine/ 2023-04-28T07:52:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/the-us-dollar-will-be-one-of-2023s-biggest-losers/ 2023-04-27T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/amicus-opfolda-wins-positive-chmp-opinion-in-pompe-disease/ 2023-05-02T08:23:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ec-announces-eu-pharma-reform-that-cuts-market-exclusivity/ 2023-04-27T17:58:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/seres-nestle-health-fda-vowst/ 2023-04-27T15:21:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/evommune-funding-therapies-chronic-inflammatory-diseases/ 2023-04-27T15:01:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/vertex-fda-cystic-fibrosis/ 2023-04-27T13:20:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-chmp-cosentyx-hs/ 2023-04-27T12:38:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bristol-myers-squib-cell-therapy/ 2023-04-27T10:36:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/chmp-roche-r-r-dlbcl-therapy/ 2023-04-27T10:09:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/lnp-manufacturing-in-the-mrna-revolution/ 2023-04-27T16:19:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/accessible-interactive-reliable-the-next-generation-in-participant-consent/ 2023-04-27T08:45:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nice-kite-car-t-therapies/ 2023-04-27T07:53:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/orbital-270m-rna-medicines/ 2023-04-27T07:51:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/click-therapeutics-kicks-off-digital-therapy-remote-trial-for-migraine/ 2023-04-26T16:42:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/atea-secures-fast-track-designation-for-covid-19-drug-bemnifosbuvir/ 2023-04-26T16:26:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/singapore-startup-albatroz-wins-financing-to-develop-solid-tumour-drugs/ 2023-04-26T15:02:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/vedanta-bacterial-consortia-therapies/ 2023-04-26T13:42:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-in8bio-inb-400-inb-410/ 2023-04-26T13:27:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mina-biomarin-rnaa-therapies/ 2023-04-26T12:43:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/myrtelle-ilap-canavan-disease/ 2023-04-26T12:09:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/buyers-guide/primary-packaging-medical-devices/ 2024-06-24T14:02:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/adcentrx-adcs-clinical-development/ 2023-04-26T10:21:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/invivyd-vyd222-prevent-covid-19/ 2023-04-26T10:06:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/akebia-chronic-kidney-disease/ 2023-04-26T08:49:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-biogen-qalsody-als/ 2023-05-10T04:25:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/breathing-easy-how-digital-inhalers-are-changing-asthma-treatment/ 2023-05-01T13:18:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/norsk-hydro-recycling-plant-in-michigan-nears-completion/ 2023-04-25T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/is-it-golds-time-to-run/ 2023-04-25T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cidara-receives-20m-payout-after-fda-backs-for-rezzayo/ 2023-04-25T19:25:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bluebird-moves-forward-in-sickle-cell-arena-with-lovo-cel-bla/ 2023-04-25T16:46:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/malaria-vaccines-must-beat-logistics-issues-for-efficient-access/ 2023-05-31T04:54:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/assertio-biopharmaceutical-spectrum/ 2023-04-25T14:33:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/amerisourcebergen-cgt-integration-hub/ 2023-05-08T14:08:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/aevitas-scfh-4d-molecular/ 2023-04-25T12:30:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/3bp-novartis-fap-targeting/ 2023-04-25T12:02:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/rhythm-imcivree-bbs-germany/ 2023-04-25T10:46:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-avidity-aoc-1044/ 2023-06-26T05:42:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/forge-aav-gene-therapies/ 2023-04-25T08:21:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eli-lilly-baqsimi-amphastar/ 2023-04-25T08:31:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nice-publishes-draft-nod-for-darzalex-combo-to-treat-multiple-myeloma/ 2023-04-24T20:49:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/everest-launches-breakthrough-iga-nephropathy-drug-in-china/ 2023-04-24T20:52:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nice-recommends-abbvies-jjs-imbruvica-for-combo-use-in-untreated-cll/ 2023-04-24T18:57:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/covid-19-vaccine-success-bolsters-nanoparticle-drug-delivery-research/ 2023-04-24T15:45:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lianbio-nda-ohcm-therapy-mavacamten/ 2023-04-24T15:16:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/apellis-marketing-applications-pegcetacoplan/ 2023-04-24T13:52:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-fda-xortx-oxypurinol/ 2023-04-24T13:39:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/ethnopharmacology-modern-drug-discovery/ 2023-04-24T11:30:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/vallon-pharmaceuticals-gri-bio/ 2023-04-24T11:18:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/biologics/ 2023-04-24T11:29:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/retinai-boehringer-geographic-atrophy/ 2023-04-24T10:17:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/virica-biotech-ontario-government/ 2023-04-24T10:18:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-hepatitis-a-vaccine/ 2023-04-24T07:58:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/european-commission-janssen-akeega/ 2023-04-24T07:58:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/otc-narcan-will-cost-less-than-50-company-says/ 2023-08-19T17:00:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-pushes-daiichi-sankyos-quizartinib-approval-date-by-three-months/ 2023-04-21T22:12:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/dea-organises-drug-take-back-day-to-fight-addiction/ 2023-04-21T16:31:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/orphalan-launches-wilson-disease-therapy/ 2023-06-15T04:10:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/samyang-lg-chem-cancer/ 2023-04-21T13:45:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/blue-water-vaccines-agrees-to-buy-verus-entadfi-capsules-business/ 2023-04-21T13:28:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/fda-approving-mirikizumab/ 2023-04-21T13:07:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/carsgen-ct041-pancreatic-cancer/ 2023-04-21T12:31:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/az-terminate-cotadutide-coagonist/ 2023-04-21T11:56:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/twist-bioscience-astellas-antibody/ 2023-04-21T10:24:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/enveda-biosciences-multiple-candidates/ 2023-04-21T09:53:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/moderna-ibm-mrna-research/ 2023-11-03T10:23:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/incyte-ec-opzelura-vitiligo/ 2023-06-07T04:23:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/three-new-manufacturing-fdi-for-vietnam/ 2023-04-20T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/maxion-scoops-2m-uk-grant-to-develop-autoimmune-disease-treatment/ 2023-04-20T19:09:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/dbv-sets-course-on-regulatory-journey-for-peanut-allergy-patch/ 2023-05-25T01:26:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abdera-advance-radiopharmaceuticals/ 2023-04-20T15:08:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/hasten-biopharmaceutic-pipeline-assets-development/ 2023-04-20T14:45:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/the-next-phase-of-decentralisation-in-clinical-trials/ 2023-04-20T16:02:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/amgen-scores-otezla-patent-win-in-court-to-keep-competition-at-bay/ 2023-04-20T14:30:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/forbion-life-sciences-funds/ 2023-04-20T14:24:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/tubulis-bristol-myers-squibb/ 2023-04-20T12:56:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/beigene-expands-us-manufacturing-and-rd-capacity-in-new-jersey/ 2023-04-21T18:06:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/targovax-plans-rebrand-circio/ 2023-04-20T09:27:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/zucara-therapeutics-fda-zt-01/ 2023-04-20T09:30:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/drugs-japan-price-reduction/ 2023-04-20T09:04:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lambda-medidata-trial-data/ 2023-04-20T09:09:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/roquette-pharmaceutical-innovation-facility/ 2023-04-20T08:32:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-roche-diffuse-large-b-cell-lymphoma/ 2023-04-20T07:12:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/investor-confidence-israel-start-up-credentials-legal-reforms/ 2023-04-19T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/medx-and-pharmachoice-team-up-for-teledermatology-screening-service/ 2023-05-25T03:55:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/neuronascent-plans-phase-ii-parkinsons-disease-trial-with-neurorestorative-drug/ 2023-04-19T16:57:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/madrigal-wins-fda-fast-track-designation-for-nash-drug/ 2023-06-23T10:53:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-colorectal-cancer-therapy-lonsurf/ 2023-04-19T14:48:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/bayer-women-health-drug/ 2023-04-19T14:43:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/johnson-johnson-reports-5-6-sales/ 2023-04-19T14:31:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/everest-sph-kyuan-xerava/ 2023-04-19T12:11:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sab-fda-influenza-immunotherapy/ 2023-04-19T11:17:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/orphelia-pharma-tanner-kimozo/ 2023-04-19T10:42:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-arcutis-seborrheic-dermatitis/ 2023-04-19T10:41:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-pfizer-biontech-moderna-covid-19/ 2023-04-19T08:52:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-buy-bellus-health/ 2023-04-19T08:12:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/heineken-finds-buyer-for-russia-assets/ 2023-04-18T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/heidelberg-materials-to-decarbonise-edmonton-cement/ 2023-04-18T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/standard-chartered-and-ifc-renew-commitment-to-boost-global-trade-by-6bn/ 2023-04-18T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-adcom-entasis-antibiotic/ 2023-04-18T17:27:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/acadia-commercialises-first-us-rett-syndrome-drug/ 2024-05-09T13:38:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-intelgenxs-rizafilm-acute-migraine-treatment/ 2023-04-18T15:56:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovators-lipase-compositions-pharmaceutical/ 2024-08-01T13:05:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovators-hiv-peptides-pharmaceutical/ 2023-04-18T14:29:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovators-anti-irritants-for-dermatological-drugs-pharmaceutical/ 2023-04-18T14:25:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovators-genetically-modified-fusion-polypeptides-pharmaceutical/ 2023-04-18T14:23:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovators-crispr-vectors-pharmaceutical/ 2024-09-09T06:22:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovators-immuno-oncology-car-t-cell-based-compositions-pharmaceutical/ 2023-05-12T13:31:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/complement-therapeutics-financing-therapies/ 2023-04-27T12:53:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-agenus-colorectal-cancer/ 2023-04-18T13:54:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gamida-cell-fda-blood-cancer/ 2023-04-18T13:37:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/china-hutchmed-fruquintinib-nda/ 2023-04-18T13:30:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/multiple-sclerosis-market-29-8-billion-by-2030/ 2023-04-18T13:14:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pipeline-therapeutics-janssen-neuroscience/ 2023-04-18T10:22:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/regulators-bristol-myers-myeloma/ 2023-04-18T10:31:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-abbvie-oral-migraine-therapy/ 2023-04-18T08:12:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lilly-1-6bn-indiana-manufacturing/ 2023-04-18T08:13:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/what-are-the-biggest-ipos-of-all-time/ 2023-04-17T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/report-womens-wellbeing-suffers-more-than-mens-in-a-hybrid-work-world/ 2023-04-17T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/interviews/ceo-of-fladgate-partnership-adrian-bridge-interview/ 2023-04-17T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-adcom-votes-in-favour-of-lundbecks-otsukas-rexulti-in-aad/ 2023-04-17T20:20:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/genmab-and-argenx-team-up-to-engineer-novel-antibody-therapies/ 2023-04-18T08:23:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/telix-revives-olaratumab-development-with-positive-preclinical-data/ 2023-04-17T15:26:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/akthelia-university-of-iceland-in-armor-project/ 2023-04-17T14:25:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/smart-immune-gates-foundation/ 2023-04-27T12:53:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-horizon-tepezza-ted-drug/ 2023-04-17T13:43:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/health-canada-pfizer-bivalent-rsv/ 2023-05-08T10:23:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/england-to-become-the-second-largest-medical-cannabis-market-europe/ 2024-03-20T03:34:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nkgen-biotech-graf-acquisition/ 2023-04-27T12:52:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/snbl-buy-satsuma-pharmaceuticals/ 2023-04-17T10:33:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/incannex-qps-cannquit-renecann/ 2023-04-17T09:28:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-buy-prometheus-biosciences/ 2023-04-17T08:13:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/going-big-how-cartridges-are-making-large-volume-high-dose-subcutaneous-autoinjectors-a-reality/ 2023-04-17T14:07:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/madrigals-resmetirom-could-have-higher-price-defence-in-nash-icer-says/ 2023-05-04T05:01:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ghana-becomes-first-country-to-approve-oxfords-malaria-vaccine/ 2023-04-14T17:44:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/torl-biotherapeutics-oncology-therapies/ 2023-04-14T15:07:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-sab-biotherapeutic/ 2023-04-14T14:59:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-rejects-lilly-uc-drug/ 2023-04-21T05:22:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/alvotech-crl-fda-avt02-bla/ 2023-04-14T13:27:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/understanding-the-role-of-recombinant-insulin-in-cell-culture-systems-what-the-studies-say/ 2023-04-14T11:48:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-ips-heart-drugs/ 2023-06-26T05:42:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/twist-tcr-car-libraries/ 2023-04-14T10:22:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ginkgo-bioworks-gd2-car-t-cell/ 2023-04-14T08:55:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/tiziana-life-foralumab-long-covid/ 2023-04-14T07:54:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/magazine-dawn-of-a-new-indication-how-to-study-drugs-for-aging/ 2023-04-21T06:29:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lebanon-sri-lanka-bolivia-drop-in-foreign-reserves-covid-19/ 2023-04-13T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/upcoming-sickle-cell-gene-therapies-cost-effective-at-2-million-says-icer/ 2023-04-27T12:52:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/dyadic-expands-covid-19-licence-with-rubic-to-bolster-vaccine-production-in-africa/ 2023-04-13T18:57:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-keytruda-chemotherapy-gastric-cancer/ 2023-04-19T10:01:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/digital-clinical-trials-trends-to-watch-in-2023/ 2023-09-19T14:42:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/takeda-aav-rare-haematology-disease/ 2023-05-22T07:22:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/unmet-needs-obesity-market/ 2023-04-14T06:44:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/alentis-develop-medicines-claudin-1/ 2023-04-13T14:40:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biogen-denali-amyloid-beta/ 2023-04-13T14:04:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pharmalex-cpharm-australia/ 2023-04-13T12:56:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/imaginab-cd8-immunopet-tracer/ 2023-04-13T13:55:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fusion-fda-ind-fpi-2068/ 2023-04-13T10:14:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/insilico-medicine-small-molecule-cdk8/ 2023-04-13T08:24:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/kala-kpi-012-fda-fast-track/ 2023-04-13T07:46:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/insulin-pricing-in-flux-as-major-pharma-players-take-action/ 2023-05-05T20:28:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-economy-hamstrung-by-sluggish-growth-at-0-1/ 2023-04-12T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/beating-inflation-compound-interest-and-tax-efficiency/ 2023-04-12T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-nordisk-and-aspect-join-forces-for-bioprinting-tissue-therapeutics/ 2023-04-12T17:37:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bmss-repotrectinib-to-have-foundationone-genomic-sequencing-companion-diagnostic/ 2023-04-12T17:33:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/panbela-flynpovi-treat-fap/ 2023-04-12T14:08:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lygenesis-imagine-pharma-diabetes/ 2023-04-12T14:08:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/xenetic-biosciences-research-tsri/ 2023-04-12T13:42:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/primate-models-in-pharma-what-the-future-holds/ 2023-04-12T13:18:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pharming-joenja-apds-us/ 2023-04-12T12:30:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/china-junshi-nsclc-combo/ 2023-04-12T10:26:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-takeda-hyqvia-pi/ 2023-04-12T10:12:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/court-ruling-hiv/ 2023-04-12T09:20:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/small-molecule-api-shining-a-spotlight-on-new-innovations-in-milling/ 2023-04-12T08:35:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cognizant-boehringer-ingelheim-medicines/ 2023-04-12T09:30:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/taiwan-shionogi-drug-covid-19/ 2023-04-12T09:21:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/oecd-report-uk-exports-have-grown-less-than-any-other-g7-country-since-2019/ 2023-04-11T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sarepta-announces-may-12-date-for-dmd-therapys-reckoning-at-the-fda/ 2023-04-12T14:22:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/health-canada-expands-orkambi-label-to-include-access-to-infants/ 2023-04-11T17:21:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/veneno-research-agreement-astellas-pharma/ 2023-04-11T15:03:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/zydus-fda-approval-antibiotic-azithromycin/ 2023-04-11T14:56:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/non-invasive-cancer-therapy/ 2023-04-12T05:40:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/michr-grant-clinical-and-translational-science/ 2023-04-11T12:00:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ctrl-cell-therapy-platform-development/ 2023-04-12T05:33:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cerner-enviza-ai-drug-safety/ 2023-04-11T10:30:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-5bn-new-covid19-vaccines/ 2023-04-11T08:43:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-government-appeals-ruling-on-abortion-medication/ 2023-04-11T07:57:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/aviceda-qub-glyco-immune-therapeutics/ 2023-04-10T12:39:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/malaysia-indication-astrazeneca-evusheld/ 2023-04-10T12:14:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/india-cipla-licence-novartis-galvus/ 2023-04-10T12:57:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/australia-gvhd-chronic-rhinosinusitis/ 2023-04-10T10:28:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approval-preterm-birth-drug-makena/ 2023-04-11T07:02:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/enanta-fda-fast-track-designation-edp-323/ 2023-04-07T11:31:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/modernas-mrna-vaccine-keytruda/ 2023-04-10T16:05:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uks-nice-olaparib-treat-cancer/ 2023-04-07T06:10:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-sketches-a-path-for-patient-focused-approach-to-drug-development/ 2023-04-07T05:11:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mhra-fast-tracks-advantages-immunomodulatory-for-alzheimers-disease/ 2023-04-06T15:42:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/verismo-therapeutics-synkir110-fda/ 2023-04-06T14:13:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/immunogen-signs-loan-agreement-pharmakon/ 2023-04-06T13:33:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ginkgo-stridebios-aav-platform/ 2023-04-06T13:43:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mirum-pfic-therapy-europe/ 2023-04-06T11:50:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/respirerx-ucl-ampakines-gria/ 2023-04-06T10:07:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/singapore-everest-iga-nephropathy/ 2023-04-06T10:06:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biotheryx-incyte-protein-degraders-oncology/ 2023-04-06T08:22:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-fda-accord-biopharmas-bla-hlx02/ 2023-04-06T08:19:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/anagram-wins-15-5m-boost-to-develop-enzyme-therapy-for-cystic-fibrosis/ 2023-07-19T04:44:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ema-upgrades-rare-disease-innovation-scheme-to-prime-time/ 2023-04-10T13:33:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/proxygen-merck-molecular-glue-degraders/ 2023-04-05T16:03:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/israel-approval-amarin-vazkepa/ 2023-04-05T16:02:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/duopharm-luye-pharma-cholesterol-management/ 2023-04-05T16:02:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/anabios-cell-systems/ 2023-04-05T14:20:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/caribou-car-t-cell-therapy/ 2023-04-27T12:51:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-eua-inflarx-covid-19/ 2023-04-05T10:00:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/absci-m2gen-cancer-drug-development/ 2023-04-05T08:17:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/shionogi-fast-track-covid-19/ 2023-04-05T08:02:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/qa-a-decade-on-whats-next-for-car-t-therapies/ 2023-04-27T12:52:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/london-crowned-european-city-highest-online-visibility/ 2023-04-04T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/janssen-launches-once-daily-option-for-prostate-cancer-drug-erleada/ 2023-04-04T17:55:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/adcendo-amps-up-adc-development-with-e82-million-series-a-extension/ 2023-04-04T17:56:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/scorpion-inks-deal-with-pierre-fabre-for-next-gen-egfr-inhibitors/ 2023-04-05T19:44:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/indian-pharma-manufacturing/ 2023-04-04T15:06:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/alzheimer-disease-fda-designation/ 2023-04-04T14:50:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/vertex-crispr-therapeutics-exa-cel/ 2023-04-04T13:55:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/agc-biologics-the-jikei-university/ 2023-04-04T13:32:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/panbela-therapeutics-johns-hopkins-ivospemin/ 2023-04-11T03:45:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/orbit-evergreen-radiopharmaceuticals/ 2023-04-04T12:11:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/innovations-in-air-filters-how-a-simple-filter-solution-is-key-to-reducing-energy-consumption/ 2023-10-26T15:29:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/chmp-astrazeneca-nmosd-therapy/ 2023-04-04T10:55:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gennova-covid-19-booster/ 2023-04-04T10:46:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/abacus-medicine-pharma-services-laboratoires-ctrs-partnership-orphacol-spain/ 2023-04-06T09:19:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-combination-therapy-la-muc/ 2023-04-04T09:19:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-mail-back-envelopes-opioids/ 2023-04-04T09:21:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ipag-business-school-anchors-new-downtown-cairo-development/ 2023-04-03T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/which-companies-are-making-the-most-foreign-investments/ 2023-04-03T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/cleanroom-tech-tackles-environmental-impact-of-consumables/ 2023-03-21T20:54:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/femtech-in-2023-covid-19-spurs-interest-in-digital-solutions/ 2023-04-03T18:26:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/new-nhs-scheme-cuts-cost-burden-for-hormone-replacement-therapies-in-the-uk/ 2023-04-03T21:11:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sartorius-upscales-gene-therapy-prowess-with-2-6bn-polyplus-acquisition/ 2023-04-03T20:46:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ec-sandoz-biosimilar-hyrimoz/ 2023-04-03T14:15:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ablaze-pharmaceuticals-liver-cancer/ 2023-04-03T13:53:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/tango-therapeutics-fda-clearance/ 2023-04-03T13:38:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biontech-dualitybio-adc-cancer/ 2023-04-03T13:28:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/innate-pharma-takeda-adcs/ 2023-04-03T11:41:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/hutchmed-fda-colorectal-cancer/ 2023-04-03T11:37:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/covid-vaccine-demand/ 2023-04-03T11:09:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/chmp-bristol-myers-squibb-breyanzi/ 2023-04-03T08:39:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eisai-national-cancer-center-tazemetostat/ 2023-04-03T11:39:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/hong-kong-singapore-crypto-company-kaiko-brain-drain/ 2023-04-02T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/small-and-medium-biotechs-jump-on-obesity-train/ 2023-03-31T18:20:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/hipras-covid-19-booster-gets-ema-nod-to-enter-uncertain-landscape/ 2023-03-31T18:14:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/medicines-patent-pool-broadens-access-to-generic-injectable-prep-for-hiv/ 2023-03-31T17:55:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-scynexis-fungal-infection/ 2023-04-14T08:01:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/moderna-mrna-manufacturing-facility/ 2023-04-27T12:51:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-fda-launches-lupus-consortium-to-confront-drug-development-challenges/ 2023-03-30T18:21:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/how-improved-plain-language-summaries-can-boost-your-ct-patient-engagement/ 2023-03-30T16:42:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/msd-secures-full-approval-for-keytrudas-use-in-msi-high-solid-tumours/ 2023-03-30T15:27:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-tackles-opioid-crisis-with-approval-of-otc-narcan/ 2023-03-30T15:22:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/fda-7bn-plans-2024/ 2024-11-22T11:04:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/thea-open-innovation-galimedix/ 2023-03-30T11:24:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/who-cough-mixture-health-alerts-raises-questions-about-slack-compliance-in-manufacturing/ 2023-03-30T09:24:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ec-regeneron-libtayo-chemotherapy/ 2023-03-30T09:19:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/alzheimers-drug-leqembi-12-9bn-by-2028/ 2023-03-30T15:32:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-boosts-life-science-innovation-with-277-million-funding/ 2023-03-30T08:15:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/vikings-weight-loss-drug-enters-an-already-crowded-arena/ 2023-03-29T17:26:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/algotx-unveils-plans-for-phase-ii-trial-for-rare-chronic-condition/ 2023-03-29T16:18:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/regeneron-sonoma-t-cell-therapies/ 2023-03-29T15:20:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/evotec-bristol-myers-squibb/ 2023-03-29T12:04:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/container-closure-integrity-testing-ccit-how-to-get-started-with-deterministic-methods/ 2023-03-29T08:36:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/a-half-decade-after-its-first-plan-japans-hydrogen-goals-remain-distant/ 2023-03-28T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/costs-rise-for-new-samsung-factory-in-texas/ 2023-03-28T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biontech-targets-infectious-diseases-for-vaccine-development/ 2023-03-31T23:14:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/oncoverity-eyes-cusatuzumab-development-in-aml-after-licensing-rights/ 2023-03-28T16:08:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/obesity-market-growth-2031/ 2023-03-28T14:53:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsks-results-tease-survival-benefit-trend-with-jemperli-for-endometrial-cancer/ 2023-03-29T04:54:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/vertex-crispr-diabetes-therapies/ 2023-03-28T10:28:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mhlw-incyte-myeloid-lymphoid/ 2023-03-28T08:12:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-consumer-confidence-has-risen-slightly-teneo-report/ 2023-03-27T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/iovance-submits-lifileucel-bla-to-us-fda/ 2023-03-27T18:39:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/novel-drug-approvals-cmo-opportunities/ 2023-03-27T14:09:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/national-resilience-domestic-biomanufacturing/ 2023-03-27T12:41:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/regenerative-medicine-vegf/ 2023-03-27T09:47:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-pharming-joenja-apds/ 2023-03-27T09:09:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-inflation-is-likely-to-fall-in-2023-but-low-to-zero-growth-is-expected/ 2023-03-26T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-companies-tired-of-challenging-business-with-china/ 2023-03-26T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/welfare-loss-and-incentives-based-fdi-competition/ 2023-03-26T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nmpa-approval-astrazeneca-calquence/ 2023-03-24T15:09:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/comparison-humira-biosimilars/ 2023-03-24T14:31:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/takeda-manufacturing-facility-japan/ 2023-03-24T12:38:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/pharma-fix-the-quest-for-the-next-tuberculosis-vaccine/ 2023-03-24T10:12:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/moderna-generation-bio-genetic-medicines/ 2023-03-24T12:36:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/coinbase-sec-warning-shows-regulators-are-coming-for-crypto/ 2023-03-23T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/pfizer-acquires-adc-pioneer-seagen/ 2023-03-23T18:28:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/biotech-post-ipo-boom/ 2023-03-23T16:11:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biohaven-hangzhou-bhv-8000/ 2023-03-23T15:46:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/new-medications-for-pcos-slowly-edge-toward-development/ 2023-05-22T08:43:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-incyte-merkel-cell-carcinoma/ 2023-03-23T12:50:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/aseptic-lyophilisation-mass-spectrometry-opportunities/ 2023-03-23T12:37:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mhra-revamps-uk-clinical-trial-regulation-with-the-promise-of-faster-timelines/ 2023-03-23T12:17:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/prometheus-pra023-crohns-disease/ 2023-03-23T09:13:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cspc-pharmaceutical-covid-19-vaccine/ 2023-03-23T12:59:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/a-guide-to-englands-eight-proposed-investment-zones/ 2023-03-22T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/optimising-biopharma-production-through-process-intensification/ 2023-03-22T16:38:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/quality-first-meeting-injectables-demand-while-staying-compliant/ 2023-03-22T14:44:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/is-rfid-the-future-of-smart-labelling/ 2023-03-22T21:03:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/right-shoring-api-production-in-europe-2/ 2023-05-15T09:59:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/thromboembolism-vte-covid-19/ 2023-03-22T14:27:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanof-dupixent-atopic-dermatitis/ 2023-03-22T08:46:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/cmo-moves-regulatory-catalysts-for-drug-manufacturing-march-2023/ 2023-03-21T18:36:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/invisishield-gladstone-respiratory-disease/ 2023-03-21T12:54:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/cannabidiol-milling-selecting-the-right-equipment-for-cbd-testing/ 2023-07-12T12:07:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gilead-nurix-protein-degrader/ 2023-03-21T09:57:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/vietnams-corruption-crackdown-paralysing-officials-worrying-investors/ 2023-03-20T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/the-new-frontiers-of-pharmaceutical-innovation-according-to-investors/ 2023-07-26T09:07:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/africa-unleashing-the-potential-of-the-new-superpower-in-clinical-trials/ 2025-07-16T12:12:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biontech-oncoc4-solid-tumours/ 2023-03-20T15:32:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/predictive-oncology-cancer-horizons/ 2023-03-20T11:20:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/first-to-market-therapy-nash/ 2023-05-04T05:01:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/rvac-pennsylvania-mrna-vaccines/ 2023-03-20T11:53:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ukraines-wartime-brain-drain-is-being-tackled-by-the-ebrd/ 2023-03-19T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pharmanovia-aeterna-zentaris-ghryvelin/ 2023-03-17T16:45:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/tapping-into-digital-therapeutics-to-improve-neurological-outcomes/ 2023-04-04T09:28:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/risk-sharing-agreements-soar-as-market-access-risk-increases/ 2023-03-17T14:48:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lcrf-daiichi-sankyo-astrazeneca/ 2023-03-18T07:02:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-novartis-tafinlar-mekinist/ 2023-03-17T09:18:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ucb-drug-discovery-aitia/ 2023-05-09T06:55:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/talem-libera-bio-ai-antibodies/ 2023-03-16T11:14:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/biotechs-silicon-valley/ 2023-03-16T15:44:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/legal-challenges-put-off-label-use-of-gender-affirming-care-drugs-in-jeopardy/ 2023-03-17T09:06:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mhra-argenx-gmg-therapy/ 2023-06-02T04:12:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/hsbc-acquires-svb-uk/ 2023-03-15T17:05:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/acelrx-pharmaceuticals-dsuvia-alora/ 2023-03-15T14:43:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-nordisk-list-prices-insulin/ 2023-03-15T11:47:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/parker-review-diversity-targets-ftse-350-firms/ 2023-03-15T11:48:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cingulate-indegene-adhd-therapy/ 2023-03-14T14:04:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/brazil-takeda-dengue-vaccine/ 2023-03-15T14:29:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovators-chemotherapy-platinum-based-cancer-drug-compositions-pharmaceutical/ 2023-04-05T07:42:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-to-buy-seagen/ 2023-03-14T12:04:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-buy-provention-bio/ 2023-03-13T15:23:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cytovance-biologics-phenotypeca-biopharmaceutical/ 2023-03-13T11:03:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-acadia-rett-syndrome/ 2023-03-13T11:40:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-pfizer-migraine-nasal-spray/ 2023-03-10T15:32:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cell-one-cbm-cell-gene/ 2023-04-27T12:47:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/pharmaceutical-prices-lebanon/ 2023-03-10T19:50:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/new-facility-boosts-uks-cell-and-gene-therapy-manufacturing-capacity/ 2023-04-27T13:04:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sandoz-biologics-production-plant/ 2023-03-10T09:27:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/spybiotech-reveals-plans-for-uk-based-hcmv-vaccine-trial-in-h2-2023/ 2023-03-10T14:03:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ucb-cancer-research-uk-oncology/ 2023-03-09T14:31:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovators-tyrosine-kinase-inhibitors-pharmaceutical/ 2024-08-29T03:35:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovators-immuno-oncology-tumour-antibody-serum-compositions-pharmaceutical/ 2023-03-09T12:32:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovators-transgenic-murine-models-pharmaceutical/ 2023-03-09T13:30:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovators-platinum-as-active-pharmaceutical-ingredient-pharmaceutical/ 2023-03-09T13:26:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovators-nucleic-acid-active-pharmaceutical-ingredient-pharmaceutical/ 2023-03-14T11:03:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovators-monoclonal-antibody-drugs-for-cancer-pharmaceutical/ 2023-03-09T12:21:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovators-mirna-chemical-synthesis-pharmaceutical/ 2023-03-09T12:19:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovators-immuno-oncology-in-vitro-t-cell-activation-pharmaceutical/ 2023-03-09T12:18:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovators-immunotherapy-for-neurodegenerative-disease-pharmaceutical/ 2023-03-09T13:21:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovators-dsdna-virus-peptides-pharmaceutical-2/ 2023-03-09T12:12:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovators-drugs-for-neuro-degenerative-disorders-pharmaceutical/ 2023-03-09T12:10:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovators-immuno-oncology-cytotoxic-t-cell-based-cancer-immunotherapy-pharmaceutical/ 2023-03-09T13:13:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovators-cell-therapy-for-ocular-disorders-pharmaceutical/ 2023-03-09T12:08:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovators-immuno-oncology-cancer-radiotherapy-pharmaceutical/ 2023-03-14T11:04:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovators-anti-hiv-compositions-pharmaceutical/ 2024-09-09T06:48:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovators-antibody-modifying-drug-conjugates-pharmaceutical/ 2023-03-14T11:13:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/modex-merck-epstein-barr-virus/ 2023-03-09T11:22:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/tessa-nci-tt11x-non-hodgkin-lymphoma/ 2023-05-05T15:26:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/danaher-university-pennsylvania-cell-therapies/ 2023-04-27T13:05:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-shorla-t-cell-leukaemia/ 2023-03-08T11:45:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/eli-lilly-price-cap/ 2023-03-08T11:04:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/caris-incyte-oncology-pipeline/ 2023-03-08T10:20:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/perimenopause-tackling-the-dearth-of-treatments-for-anxiety-and-depression/ 2023-08-09T04:11:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/global-fdi-outperformed-ma-in-2022/ 2023-03-07T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/cnm-au8-multiple-sclerosis/ 2023-03-07T16:19:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/one-medical-ceo-rebuts-amazon-data-privacy-concerns/ 2023-03-09T14:04:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/abacus-medicine-pharma-services-addmedica-sign-partnership/ 2023-03-07T11:35:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/accurate-dosing-how-to-achieve-maximum-precision-with-poor-flowing-products/ 2023-03-14T14:43:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/teijin-pharma-novartis-kidney-disease/ 2023-03-07T08:29:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/tuoyi-treatment-npc/ 2023-03-06T14:23:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/dawn-of-a-new-indication-how-to-study-drugs-for-aging/ 2023-03-06T20:19:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/incannex-catalent-psilocybin/ 2023-03-06T11:31:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/how-to-control-the-freeze-drying-process-in-demanding-conditions/ 2023-03-06T10:07:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-lilly-breast-cancer/ 2023-03-06T10:13:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/vw-eyes-na-scout-and-battery-plants-reports/ 2023-03-05T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/vemurafenib-f-hoffmann-la-roche-sarcomas-likelihood-of-approval/ 2025-01-19T16:40:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/vemurafenib-f-hoffmann-la-roche-thyroid-cancer-likelihood-of-approval/ 2025-01-19T16:40:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/vemurafenib-f-hoffmann-la-roche-neuroblastoma-likelihood-of-approval/ 2025-01-19T16:43:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/vh-4011499a-viiv-healthcare-human-immunodeficiency-virus-hiv-infections-aids-likelihood-of-approval/ 2024-04-19T00:56:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sibeprenlimab-visterra-iga-nephropathy-berger-s-disease-likelihood-of-approval/ 2023-07-01T02:09:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/vlx-1005-veralox-therapeutics-heparin-induced-thrombocytopenia-likelihood-of-approval/ 2025-01-19T16:59:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/vonoprazan-acetate-jiangsu-carephar-pharmaceutical-duodenal-ulcer-likelihood-of-approval/ 2023-05-30T17:51:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/vorolanib-eyepoint-pharmaceuticals-wet-neovascular-exudative-macular-degeneration-likelihood-of-approval/ 2025-01-19T16:51:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/vrdn-002-viridian-therapeutics-graves-ophthalmopathy-likelihood-of-approval/ 2024-01-24T18:01:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/vvn-539-viva-vision-biotech-open-angle-glaucoma-likelihood-of-approval/ 2023-03-04T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ucart20x22-cellectis-mantle-cell-lymphoma-likelihood-of-approval/ 2025-01-19T16:59:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ucart20x22-cellectis-marginal-zone-b-cell-lymphoma-likelihood-of-approval/ 2025-01-19T17:00:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ucart20x22-cellectis-primary-mediastinal-b-cell-lymphoma-likelihood-of-approval/ 2025-01-19T17:00:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ucart20x22-cellectis-follicular-lymphoma-likelihood-of-approval/ 2025-01-19T17:01:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ucart-22-cellectis-b-cell-acute-lymphocytic-leukemia-b-cell-acute-lymphoblastic-leukaemia-likelihood-of-approval/ 2025-01-19T17:16:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tocilizumab-biosimilar-celltrion-rheumatoid-arthritis-likelihood-of-approval/ 2025-01-19T16:57:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ulixertinib-biomed-valley-discoveries-colorectal-cancer-likelihood-of-approval/ 2024-07-05T18:27:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tozorakimab-astrazeneca-asthma-likelihood-of-approval/ 2025-01-19T16:52:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tp-04-tarsus-pharmaceuticals-rosacea-likelihood-of-approval/ 2025-01-19T16:56:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/uwc-19-uwell-biopharma-chronic-lymphocytic-leukemia-cll-likelihood-of-approval/ 2024-09-09T01:46:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/valemetostat-daiichi-sankyo-peripheral-t-cell-lymphomas-ptcl-likelihood-of-approval/ 2025-01-19T16:53:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/samelisant-suven-life-sciences-narcolepsy-likelihood-of-approval/ 2023-07-31T00:54:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/stp-938-step-pharma-marginal-zone-b-cell-lymphoma-likelihood-of-approval/ 2025-01-19T16:56:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/subasumstat-takeda-pharmaceutical-solid-tumor-likelihood-of-approval/ 2024-06-19T15:59:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tertomotide-gemvax-kael-alzheimer-s-disease-likelihood-of-approval/ 2025-01-19T16:41:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/testosterone-tridecanoate-lipocine-hepatic-encephalopathy-likelihood-of-approval/ 2024-05-20T01:48:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/clotrimazole-laboratorios-salvat-otitis-externa-likelihood-of-approval/ 2024-04-19T00:43:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/selinexor-karyopharm-therapeutics-myelofibrosis-likelihood-of-approval/ 2025-01-19T16:43:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/selinexor-karyopharm-therapeutics-burkitt-lymphoma-likelihood-of-approval/ 2025-01-19T16:44:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sng-162-shenogen-pharma-group-metastatic-hepatocellular-carcinoma-hcc-likelihood-of-approval/ 2025-01-21T16:58:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sepiapterin-ptc-therapeutics-phenylketonuria-pku-likelihood-of-approval/ 2025-01-19T16:55:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tagraxofusp-stemline-therapeutics-systemic-mastocytosis-likelihood-of-approval/ 2025-01-19T16:40:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tagraxofusp-stemline-therapeutics-myelofibrosis-likelihood-of-approval/ 2025-01-19T16:40:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/soticlestat-takeda-pharmaceutical-lennox-gastaut-syndrome-likelihood-of-approval/ 2024-06-19T16:08:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sotorasib-amgen-colorectal-cancer-likelihood-of-approval/ 2025-01-19T16:54:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/talditercept-alfa-biohaven-spinal-muscular-atrophy-sma-likelihood-of-approval/ 2025-01-19T16:44:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sh-748-nanjing-sanhome-pharmaceutical-marginal-zone-b-cell-lymphoma-likelihood-of-approval/ 2025-01-21T16:51:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/shra-1904-jiangsu-hengrui-medicine-solid-tumor-likelihood-of-approval/ 2025-01-19T16:57:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/shra-1904-jiangsu-hengrui-medicine-pancreatic-cancer-likelihood-of-approval/ 2025-01-19T16:58:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/shra-1904-jiangsu-hengrui-medicine-gastroesophageal-ge-junction-carcinomas-likelihood-of-approval/ 2025-01-19T16:59:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/shra-1904-jiangsu-hengrui-medicine-gastric-cancer-likelihood-of-approval/ 2025-01-19T17:00:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/shra-1921-jiangsu-hengrui-medicine-solid-tumor-likelihood-of-approval/ 2025-01-19T16:59:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ry-103-neuracle-science-neurodegenerative-diseases-likelihood-of-approval/ 2024-07-05T18:19:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ryz-101-rayzebio-neuroendocrine-gastroenteropancreatic-tumors-gep-net-likelihood-of-approval/ 2025-01-19T17:01:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/s-64315-les-laboratoires-servier-acute-myelocytic-leukemia-aml-acute-myeloblastic-leukemia-likelihood-of-approval/ 2025-01-19T16:54:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/s-65487-les-laboratoires-servier-acute-myelocytic-leukemia-aml-acute-myeloblastic-leukemia-likelihood-of-approval/ 2024-06-19T15:59:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/s-65487-les-laboratoires-servier-refractory-acute-myeloid-leukemia-likelihood-of-approval/ 2024-09-09T05:53:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/s-65487-les-laboratoires-servier-mantle-cell-lymphoma-likelihood-of-approval/ 2024-09-09T05:53:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/s-65487-les-laboratoires-servier-relapsed-acute-myeloid-leukemia-likelihood-of-approval/ 2024-09-09T05:53:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/s-65487-les-laboratoires-servier-follicular-lymphoma-likelihood-of-approval/ 2024-09-09T05:53:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/s-65487-les-laboratoires-servier-refractory-multiple-myeloma-likelihood-of-approval/ 2024-09-09T05:53:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/s-65487-les-laboratoires-servier-diffuse-large-b-cell-lymphoma-likelihood-of-approval/ 2024-09-09T05:53:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/s-65487-les-laboratoires-servier-marginal-zone-b-cell-lymphoma-likelihood-of-approval/ 2024-09-09T05:53:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sabatolimab-novartis-myelofibrosis-likelihood-of-approval/ 2024-02-21T17:55:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sabatolimab-novartis-post-polycythemia-vera-myelofibrosis-ppv-mf-likelihood-of-approval/ 2024-02-21T17:57:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/siremadlin-succinate-novartis-myelofibrosis-likelihood-of-approval/ 2025-01-19T16:44:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/siremadlin-succinate-novartis-post-essential-thrombocythemia-myelofibrosis-post-et-mf-likelihood-of-approval/ 2025-01-19T16:44:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/siremadlin-succinate-novartis-post-polycythemia-vera-myelofibrosis-ppv-mf-likelihood-of-approval/ 2025-01-19T16:45:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bristol-myers-ec-marketing-anaemia/ 2023-03-03T15:16:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ipsen-purchase-albireo-pharma/ 2023-03-03T11:42:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/how-a-specialized-commercial-program-management-team-can-improve-your-customer-experience-and-accelerate-commercialization/ 2023-10-18T14:35:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/confo-lilly-peripheral-pain-candidate/ 2023-03-06T08:07:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/rituximab-biosimilar-shanghai-henlius-biotech-splenic-marginal-zone-b-cell-lymphoma-likelihood-of-approval/ 2025-01-19T16:51:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pp-01-pleopharma-substance-drug-abuse-likelihood-of-approval/ 2025-01-19T16:59:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/quisovalimab-avalo-therapeutics-asthma-likelihood-of-approval/ 2023-05-31T19:12:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/forimtamig-f-hoffmann-la-roche-refractory-multiple-myeloma-likelihood-of-approval/ 2025-01-19T16:56:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/forimtamig-f-hoffmann-la-roche-relapsed-multiple-myeloma-likelihood-of-approval/ 2025-01-19T16:59:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ranibizumab-sr-f-hoffmann-la-roche-diabetic-retinopathy-likelihood-of-approval/ 2025-01-19T16:52:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ranibizumab-sr-f-hoffmann-la-roche-diabetic-macular-edema-likelihood-of-approval/ 2025-01-19T17:16:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/rec-163964-recursion-pharmaceuticals-clostridioides-difficile-infections-clostridium-difficile-associated-disease-likelihood-of-approval/ 2023-07-01T01:29:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pf-07261271-pfizer-inflammatory-bowel-disease-likelihood-of-approval/ 2023-09-14T23:56:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/prt-2527-prelude-therapeutics-sarcomas-likelihood-of-approval/ 2025-01-19T16:35:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/patritumab-deruxtecan-daiichi-sankyo-metastatic-breast-cancer-likelihood-of-approval/ 2025-01-19T16:51:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/patritumab-deruxtecan-daiichi-sankyo-triple-negative-breast-cancer-tnbc-likelihood-of-approval/ 2025-01-19T16:51:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pl-001-pell-bio-med-technology-primary-mediastinal-b-cell-lymphoma-likelihood-of-approval/ 2024-06-14T01:34:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pl-001-pell-bio-med-technology-diffuse-large-b-cell-lymphoma-likelihood-of-approval/ 2024-06-14T01:38:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pbcar-20a-precision-biosciences-refractory-chronic-lymphocytic-leukemia-cll-likelihood-of-approval/ 2024-01-08T18:26:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pbcar-20a-precision-biosciences-relapsed-chronic-lymphocytic-leukemia-cll-likelihood-of-approval/ 2024-01-08T18:28:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pds-0101-pds-biotechnology-head-and-neck-cancer-likelihood-of-approval/ 2024-05-20T01:32:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/dubais-new-family-office-rules-can-drive-economic-growth-for-the-uae/ 2023-03-02T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/rgx-202-regenxbio-duchenne-muscular-dystrophy-likelihood-of-approval/ 2025-01-19T17:18:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/rintatolimod-aim-immunotech-melanoma-likelihood-of-approval/ 2025-01-19T16:41:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/peltopepimut-s-isa-pharmaceuticals-oropharyngeal-cancer-likelihood-of-approval/ 2024-07-05T01:49:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/poseltinib-hanmi-pharmaceuticals-diffuse-large-b-cell-lymphoma-likelihood-of-approval/ 2025-01-19T16:45:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-issues-continuous-manufacturing-advice-to-build-an-agile-pharma-industry/ 2023-03-02T15:21:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-fda-reata-skyclarys-friedreichs-ataxia/ 2023-07-24T04:34:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-group-net-sales/ 2023-03-02T14:30:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/vertex-immunogen-conditioning-agents/ 2023-03-02T10:31:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/oragenics-inspirevax-covid-19-vaccine/ 2023-03-02T09:49:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/neratinib-puma-biotechnology-gastric-cancer-likelihood-of-approval/ 2025-01-19T16:39:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mrg-002-shanghai-miracogen-human-epidermal-growth-factor-receptor-2-positive-breast-cancer-her2-breast-cancer-likelihood-of-approval/ 2025-01-19T16:54:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/neratinib-puma-biotechnology-ovarian-cancer-likelihood-of-approval/ 2025-01-19T16:39:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mrg-002-shanghai-miracogen-metastatic-transitional-urothelial-tract-cancer-likelihood-of-approval/ 2025-01-19T16:54:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/neratinib-puma-biotechnology-esophageal-cancer-likelihood-of-approval/ 2025-01-19T16:40:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/neratinib-puma-biotechnology-human-epidermal-growth-factor-receptor-2-negative-breast-cancer-her2-breast-cancer-likelihood-of-approval/ 2025-01-19T16:40:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/neratinib-puma-biotechnology-pancreatic-cancer-likelihood-of-approval/ 2025-01-19T16:40:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mrna-1010-moderna-seasonal-influenza-likelihood-of-approval/ 2023-03-01T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mrna-1045-moderna-respiratory-syncytial-virus-rsv-infections-likelihood-of-approval/ 2025-01-19T17:00:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mrna-1230-moderna-respiratory-syncytial-virus-rsv-infections-likelihood-of-approval/ 2025-01-19T16:58:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/men-1703-stemline-therapeutics-relapsed-acute-myeloid-leukemia-likelihood-of-approval/ 2024-05-20T01:35:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/men-1703-stemline-therapeutics-refractory-acute-myeloid-leukemia-likelihood-of-approval/ 2024-05-20T01:38:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/obinutuzumab-f-hoffmann-la-roche-nephrotic-syndrome-likelihood-of-approval/ 2024-09-09T01:37:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/methotrexate-aldeyra-therapeutics-retinitis-pigmentosa-retinitis-likelihood-of-approval/ 2023-07-08T01:19:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/obx-115-obsidian-therapeutics-metastatic-melanoma-likelihood-of-approval/ 2025-01-19T17:17:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mezagitamab-takeda-pharmaceutical-iga-nephropathy-berger-s-disease-likelihood-of-approval/ 2024-07-05T01:41:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nipocalimab-johnson-johnson-chronic-inflammatory-demyelinating-polyneuropathy-cidp-likelihood-of-approval/ 2025-01-21T17:00:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/odronextamab-regeneron-pharmaceuticals-diffuse-large-b-cell-lymphoma-likelihood-of-approval/ 2025-01-19T16:45:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mti-201-modulation-therapeutics-metastatic-uveal-melanoma-likelihood-of-approval/ 2025-01-19T16:54:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mitazalimab-alligator-bioscience-melanoma-likelihood-of-approval/ 2025-01-21T16:58:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mitazalimab-alligator-bioscience-non-small-cell-lung-cancer-likelihood-of-approval/ 2025-01-21T16:58:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/navtemadlin-kartos-therapeutics-relapsed-acute-myeloid-leukemia-likelihood-of-approval/ 2025-01-19T16:42:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ukraine-war-land-rush-hurt-poorer-countries-the-most/ 2023-03-01T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nbi-1070770-neurocrine-biosciences-major-depressive-disorder-likelihood-of-approval/ 2024-04-19T00:57:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nnc0519-0130-novo-nordisk-obesity-likelihood-of-approval/ 2024-05-20T01:49:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/opinion/opinion-new-brexit-deal-can-only-be-a-good-thing-for-northern-ireland/ 2023-03-01T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/orca-q-orca-biosystems-acute-lymphocytic-leukemia-all-acute-lymphoblastic-leukemia-likelihood-of-approval/ 2024-09-09T01:48:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/orca-q-orca-biosystems-chronic-myelocytic-leukemia-cml-chronic-myeloid-leukemia-likelihood-of-approval/ 2024-09-09T01:48:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/orca-q-orca-biosystems-acute-myelocytic-leukemia-aml-acute-myeloblastic-leukemia-likelihood-of-approval/ 2024-09-09T01:51:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/magazine-right-shoring-api-production-in-europe/ 2023-04-12T06:43:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/nubeqa-bayer-prostate-cancer/ 2023-03-15T08:47:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/venture-financing-apac/ 2023-03-01T17:15:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/tevard-biosciences-vertex-trna-therapies/ 2023-03-01T15:52:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-regeneron-sanofi-polymyalgia-rheumatica/ 2023-03-01T11:25:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/rna-based-therapeutics/ 2023-06-08T04:39:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sunshine-biopharma-covid-19-treatment/ 2023-03-01T12:03:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/kite-363-gilead-sciences-diffuse-large-b-cell-lymphoma-likelihood-of-approval/ 2025-01-19T16:57:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/kl-1333m-what-is-the-likelihood-that-drug-will-be-approved/ 2023-08-10T17:34:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/knx-100-kinoxis-therapeutics-opium-opioid-addiction-likelihood-of-approval/ 2023-05-30T16:30:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lp-118-newave-pharmaceutical-relapsed-acute-myeloid-leukemia-likelihood-of-approval/ 2024-07-05T18:21:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lp-118-newave-pharmaceutical-refractory-acute-myeloid-leukemia-likelihood-of-approval/ 2024-07-05T18:21:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/brexanolone-lipocine-post-partum-depression-maternal-depression-postnatal-depression-likelihood-of-approval/ 2024-05-20T01:53:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ivonescimab-akeso-small-cell-lung-cancer-likelihood-of-approval/ 2025-01-19T16:35:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ivxa-12-icosavax-respiratory-syncytial-virus-rsv-infections-likelihood-of-approval/ 2023-07-01T01:44:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ixoberogene-soroparvovec-adverum-biotechnologies-wet-neovascular-exudative-macular-degeneration-likelihood-of-approval/ 2025-01-21T17:02:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/izalontamab-systimmune-triple-negative-breast-cancer-tnbc-likelihood-of-approval/ 2025-01-19T16:52:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/jab-3312-abbvie-non-small-cell-lung-cancer-likelihood-of-approval/ 2025-01-21T16:52:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lutetium-lu-177-vipivotide-tetraxetan-advanced-accelerator-applications-hormone-sensitive-prostate-cancer-likelihood-of-approval/ 2025-01-19T16:57:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/jaktinib-hydrochloride-what-is-the-likelihood-that-drug-will-be-approved/ 2023-08-10T17:36:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/jjo-686-novartis-b-cell-acute-lymphocytic-leukemia-b-cell-acute-lymphoblastic-leukaemia-likelihood-of-approval/ 2025-01-19T16:55:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ly-3537021-eli-lilly-and-co-type-2-diabetes-likelihood-of-approval/ 2023-02-28T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/inotuzumab-ozogamicin-pfizer-acute-lymphocytic-leukemia-all-acute-lymphoblastic-leukemia-likelihood-of-approval/ 2024-01-08T18:01:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/inotuzumab-ozogamicin-pfizer-chronic-myelocytic-leukemia-cml-chronic-myeloid-leukemia-likelihood-of-approval/ 2024-01-08T18:05:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lysergic-acid-diethylamide-mind-medicine-mindmed-major-depressive-disorder-likelihood-of-approval/ 2025-01-19T16:55:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lysergic-acid-diethylamide-mind-medicine-mindmed-generalized-anxiety-disorder-gad-likelihood-of-approval/ 2025-01-19T16:57:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/jnj-79635322-johnson-johnson-refractory-multiple-myeloma-likelihood-of-approval/ 2025-01-19T16:59:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lyt-200-puretech-health-myelodysplastic-syndrome-likelihood-of-approval/ 2024-06-14T01:29:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/jnj-79635322-johnson-johnson-relapsed-multiple-myeloma-likelihood-of-approval/ 2025-01-19T17:00:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/jnj-8543-johnson-johnson-splenic-marginal-zone-b-cell-lymphoma-likelihood-of-approval/ 2025-01-19T16:58:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/jnj-8543-johnson-johnson-follicular-lymphoma-likelihood-of-approval/ 2025-01-19T17:01:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/jnj-8543-johnson-johnson-waldenstrom-macroglobulinemia-lymphoplasmacytic-lymphoma-likelihood-of-approval/ 2025-01-19T17:17:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/international-firms-keep-doing-business-with-russia-ukraine/ 2023-02-28T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/iov-4001-iovance-biotherapeutics-non-small-cell-lung-cancer-likelihood-of-approval/ 2024-04-19T00:48:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mazdutide-eli-lilly-and-co-obesity-likelihood-of-approval/ 2025-01-19T16:54:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/iov-4001-iovance-biotherapeutics-metastatic-melanoma-likelihood-of-approval/ 2024-04-19T00:54:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mb-106-mustang-bio-follicular-lymphoma-likelihood-of-approval/ 2025-01-19T16:55:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mb-106-mustang-bio-diffuse-large-b-cell-lymphoma-likelihood-of-approval/ 2025-01-19T16:55:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mb-106-mustang-bio-relapsed-chronic-lymphocytic-leukemia-cll-likelihood-of-approval/ 2025-01-19T16:58:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/livmoniplimab-abbvie-non-small-cell-lung-cancer-likelihood-of-approval/ 2025-01-19T16:45:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mbx-2109-mbx-biosciences-inc-hypoparathyroidism-likelihood-of-approval/ 2023-05-30T18:42:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/resolving-challenges-with-product-recovery-in-biopharma-manufacturing/ 2023-02-28T17:31:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/diagnosing-and-monitoring-nafld-nash/ 2023-05-04T05:00:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/rare-disease-partnership-champions-market-access-in-south-america/ 2023-03-07T16:20:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eucure-biopharma-chipscreen-yh008/ 2023-02-28T14:29:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/dr-reddys-generic-products-mayne/ 2023-02-28T12:01:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/rare-disease-day-why-raising-awareness-is-essential-for-a-fairer-future/ 2024-01-29T16:45:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/rhythm-biotech-company-xinvento/ 2023-02-28T11:50:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/clobetasol-propionate-salicylic-acid-tretinoin-urea-gen-ilac-ve-saglik-urunleri-plaque-psoriasis-psoriasis-vulgaris-likelihood-of-approval/ 2023-05-31T18:19:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/epeleuton-afimmune-biopharma-sickle-cell-disease-likelihood-of-approval/ 2025-01-19T16:53:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/iae-0972-sunho-china-biopharmaceutical-squamous-non-small-cell-lung-cancer-likelihood-of-approval/ 2025-01-19T17:01:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/gnospv-01-geneos-therapeutics-hormone-sensitive-prostate-cancer-likelihood-of-approval/ 2025-01-21T17:00:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ibezapolstat-acurx-pharmaceuticals-clostridioides-difficile-infections-clostridium-difficile-associated-disease-likelihood-of-approval/ 2024-04-19T00:43:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ibi-110-innovent-biologics-adenocarcinoma-of-the-gastroesophageal-junction-likelihood-of-approval/ 2024-07-05T01:41:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ibi-110-innovent-biologics-gastric-cancer-likelihood-of-approval/ 2024-07-05T01:42:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/equ-001-equilibre-biopharmaceuticals-epilepsy-likelihood-of-approval/ 2024-01-24T18:02:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ibi-110-innovent-biologics-squamous-non-small-cell-lung-cancer-likelihood-of-approval/ 2024-07-05T01:44:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ic9-car-19-bellicum-pharmaceuticals-b-cell-acute-lymphocytic-leukemia-b-cell-acute-lymphoblastic-leukaemia-likelihood-of-approval/ 2025-01-19T16:55:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/garadacimab-csl-idiopathic-pulmonary-fibrosis-likelihood-of-approval/ 2025-01-19T16:43:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ifinatamab-deruxtecan-daiichi-sankyo-small-cell-lung-cancer-likelihood-of-approval/ 2025-01-19T16:52:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/etrasimod-pfizer-eosinophilic-esophagitis-likelihood-of-approval/ 2025-01-19T16:45:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/gd2-sada-y-mabs-therapeutics-solid-tumor-likelihood-of-approval/ 2025-01-21T16:53:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/gd2-sada-y-mabs-therapeutics-small-cell-lung-cancer-likelihood-of-approval/ 2025-01-21T16:53:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/gd2-sada-y-mabs-therapeutics-melanoma-likelihood-of-approval/ 2025-01-21T16:53:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/gd2-sada-y-mabs-therapeutics-sarcomas-likelihood-of-approval/ 2025-01-21T16:53:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ext-608-extend-biosciences-hypoparathyroidism-likelihood-of-approval/ 2023-05-30T16:21:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/fasedienol-vistagen-therapeutics-anxiety-disorders-likelihood-of-approval/ 2025-01-19T16:43:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/feladilimab-gsk-non-small-cell-lung-cancer-likelihood-of-approval/ 2025-01-19T16:42:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/enfortumab-vedotin-astellas-pharma-peritoneal-cancer-likelihood-of-approval/ 2025-01-19T16:41:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/enfortumab-vedotin-astellas-pharma-fallopian-tube-cancer-likelihood-of-approval/ 2025-01-19T16:43:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/enfortumab-vedotin-astellas-pharma-epithelial-ovarian-cancer-likelihood-of-approval/ 2025-01-19T16:51:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hrs-7085-jiangsu-hengrui-medicine-inflammatory-bowel-disease-likelihood-of-approval/ 2025-01-19T16:59:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ensomafusp-alfa-f-hoffmann-la-roche-diffuse-large-b-cell-lymphoma-likelihood-of-approval/ 2025-01-19T17:00:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ensomafusp-alfa-f-hoffmann-la-roche-marginal-zone-b-cell-lymphoma-likelihood-of-approval/ 2025-01-19T17:00:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/gh-002-gh-research-treatment-resistant-depression-likelihood-of-approval/ 2023-05-30T18:08:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/gi-301-yuhan-chronic-urticaria-or-hives-likelihood-of-approval/ 2025-01-19T16:35:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/gi-301-yuhan-allergic-asthma-likelihood-of-approval/ 2025-01-19T16:35:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/cmo-moves-regulatory-catalysts-for-drug-manufacturing-february/ 2023-02-27T18:33:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/orion-darolutamide-japan-prostate-cancer/ 2023-03-15T08:47:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/china-daiichi-sankyo-breast-cancer/ 2023-02-27T11:44:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/ivt-rna-vaccine-therapeutics-manufacturing/ 2024-02-28T10:29:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/chmp-merck-ridgebacks-covid-19/ 2023-02-27T08:40:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/is-the-microbiome-therapy-hype-up-for-a-reckoning/ 2023-03-08T18:32:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/edp-323-enanta-pharmaceuticals-respiratory-syncytial-virus-rsv-infections-likelihood-of-approval/ 2023-05-30T18:18:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cyb-003-cybin-major-depressive-disorder-likelihood-of-approval/ 2023-02-26T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cetuximab-biobetter-shanghai-henlius-biotech-squamous-non-small-cell-lung-cancer-likelihood-of-approval/ 2025-01-19T16:52:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/dnl-343-denali-therapeutics-amyotrophic-lateral-sclerosis-likelihood-of-approval/ 2023-07-01T01:43:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/dac-002-hangzhou-dac-biotech-small-cell-lung-cancer-likelihood-of-approval/ 2024-03-18T17:26:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/dac-002-hangzhou-dac-biotech-triple-negative-breast-cancer-tnbc-likelihood-of-approval/ 2024-03-18T17:34:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/docetaxel-starpharma-pancreatic-cancer-likelihood-of-approval/ 2024-07-05T01:28:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/elraglusib-actuate-therapeutics-myelofibrosis-likelihood-of-approval/ 2025-01-21T16:59:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/elraglusib-actuate-therapeutics-post-polycythemia-vera-myelofibrosis-ppv-mf-likelihood-of-approval/ 2025-01-21T16:59:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/elranatamab-pfizer-multiple-myeloma-kahler-disease-likelihood-of-approval/ 2024-07-05T01:44:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/elsubrutinib-abbvie-systemic-lupus-erythematosus-likelihood-of-approval/ 2023-05-30T17:46:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/datopotamab-deruxtecan-daiichi-sankyo-non-small-cell-lung-cancer-likelihood-of-approval/ 2025-01-19T16:35:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/datopotamab-deruxtecan-daiichi-sankyo-human-epidermal-growth-factor-receptor-2-negative-breast-cancer-her2-breast-cancer-likelihood-of-approval/ 2025-01-19T16:35:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/clenbuterol-hydrochloride-curasen-therapeutics-parkinson-s-disease-likelihood-of-approval/ 2023-05-30T17:02:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cnty-101-century-therapeutics-marginal-zone-b-cell-lymphoma-likelihood-of-approval/ 2025-01-19T16:59:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/defactinib-hydrochloride-verastem-ovarian-cancer-likelihood-of-approval/ 2025-01-19T16:41:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/denosumab-biosimilar-samsung-bioepis-post-menopausal-osteoporosis-likelihood-of-approval/ 2023-02-26T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/crizanlizumab-novartis-post-polycythemia-vera-myelofibrosis-ppv-mf-likelihood-of-approval/ 2023-06-01T04:31:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/csti-500-consynance-therapeutics-prader-willi-syndrome-pws-likelihood-of-approval/ 2023-05-31T19:06:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/dexmethylphenidate-hydrochloride-cingulate-attention-deficit-hyperactivity-disorder-adhd-likelihood-of-approval/ 2023-06-01T04:42:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bay-3283142-bayer-chronic-kidney-disease-chronic-renal-failure-likelihood-of-approval/ 2025-01-19T16:59:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bbt-401-bridge-biotherapeutics-ulcerative-colitis-likelihood-of-approval/ 2023-05-31T17:44:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/belantamab-mafodotin-gsk-relapsed-multiple-myeloma-likelihood-of-approval/ 2025-01-19T16:45:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/belantamab-mafodotin-gsk-amyloidosis-likelihood-of-approval/ 2025-01-19T16:51:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/camrelizumab-jiangsu-hengrui-medicine-triple-negative-breast-cancer-tnbc-likelihood-of-approval/ 2025-01-19T16:54:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bersiporocin-daewoong-pharmaceutical-idiopathic-pulmonary-fibrosis-likelihood-of-approval/ 2025-01-19T16:44:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/camrelizumab-jiangsu-hengrui-medicine-gastric-cancer-likelihood-of-approval/ 2025-01-19T16:44:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/avutometinib-potassium-verastem-ovarian-cancer-likelihood-of-approval/ 2025-01-19T16:39:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/botensilimab-agenus-metastatic-colorectal-cancer-likelihood-of-approval/ 2025-01-19T16:54:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cardiamp-biocardia-systolic-heart-failure-likelihood-of-approval/ 2024-06-19T16:01:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/botensilimab-agenus-colorectal-cancer-likelihood-of-approval/ 2025-01-19T16:54:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/br-1018-boryung-pharmaceutical-hypercholesterolemia-likelihood-of-approval/ 2024-04-19T00:58:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/survodutide-boehringer-ingelheim-international-obesity-likelihood-of-approval/ 2025-01-19T16:56:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/azd-5462-astrazeneca-congestive-heart-failure-heart-failure-likelihood-of-approval/ 2025-01-19T16:59:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/azd-6793-astrazeneca-inflammation-likelihood-of-approval/ 2025-01-21T16:54:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/aspirin-hyloris-pharmaceuticals-acute-coronary-syndrome-likelihood-of-approval/ 2024-04-19T00:57:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/biib-113-biogen-alzheimer-s-disease-likelihood-of-approval/ 2023-05-31T16:56:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bt-5528-bicycle-therapeutics-transitional-cell-cancer-urothelial-cell-cancer-likelihood-of-approval/ 2025-01-19T16:54:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/at-278-arecor-therapeutics-type-2-diabetes-likelihood-of-approval/ 2024-07-05T01:41:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/blb-201-blue-lake-biotechnology-respiratory-syncytial-virus-rsv-infections-likelihood-of-approval/ 2023-07-31T00:47:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/barzolvolimab-celldex-therapeutics-prurigo-likelihood-of-approval/ 2025-01-19T16:57:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bmb-101-bright-minds-biosciences-dravet-syndrome-severe-myoclonic-epilepsy-of-infancy-likelihood-of-approval/ 2025-01-19T16:58:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bmnd-08-biomind-labs-alzheimer-s-disease-likelihood-of-approval/ 2023-05-30T18:22:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bx-004-biomx-cystic-fibrosis-likelihood-of-approval/ 2023-05-30T18:02:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/inaxaplin-vertex-pharmaceuticals-net-present-value/ 2024-05-16T02:05:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ace-1831-acepodia-b-cell-non-hodgkin-lymphoma-likelihood-of-approval/ 2025-01-19T16:57:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lemzoparlimab-i-mab-net-present-value/ 2024-07-02T02:04:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/acoramidis-hydrochloride-bridgebio-pharma-familial-amyloid-cardiomyopathy-likelihood-of-approval/ 2025-01-19T16:56:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/rapcabtagene-autoleucel-novartis-net-present-value/ 2024-04-16T17:01:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nivolumab-relatlimab-bristol-myers-squibb-adenocarcinoma-of-the-gastroesophageal-junction-likelihood-of-approval/ 2025-01-21T16:51:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/and-017-kind-pharmaceuticals-anemia-in-chronic-kidney-disease-renal-anemia-likelihood-of-approval/ 2025-01-19T16:57:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ad-109-apnimed-obstructive-sleep-apnea-likelihood-of-approval/ 2023-05-31T17:07:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/ad-218-addpharma-mixed-dyslipidemia-likelihood-of-approval/ 2023-02-24T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nivolumab-relatlimab-bristol-myers-squibb-gastric-cancer-likelihood-of-approval/ 2025-01-21T16:51:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/annamycin-moleculin-biotech-relapsed-acute-myeloid-leukemia-likelihood-of-approval/ 2024-09-09T01:36:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/annamycin-moleculin-biotech-refractory-acute-myeloid-leukemia-likelihood-of-approval/ 2024-09-09T01:36:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ociperlimab-beigene-net-present-value/ 2024-12-13T02:50:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/anti-cd19-car-kecellitics-biotech-b-cell-leukemia-likelihood-of-approval/ 2025-01-19T16:56:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/1928zt-2-wellington-zhaotai-therapies-b-cell-acute-lymphocytic-leukemia-b-cell-acute-lymphoblastic-leukaemia-likelihood-of-approval/ 2025-01-19T16:53:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/imlunestrant-tosylate-eli-lilly-and-co-net-present-value/ 2024-07-02T02:09:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/anv-419-anaveon-colorectal-cancer-likelihood-of-approval/ 2025-01-19T16:54:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/anv-419-anaveon-non-small-cell-lung-cancer-likelihood-of-approval/ 2025-01-19T16:54:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/anv-419-anaveon-pancreatic-cancer-likelihood-of-approval/ 2025-01-19T16:55:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/encaleret-bridgebio-pharma-net-present-value/ 2024-12-13T02:53:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/anv-419-anaveon-hepatocellular-carcinoma-likelihood-of-approval/ 2025-01-19T16:56:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/anv-419-anaveon-renal-cell-carcinoma-likelihood-of-approval/ 2025-01-19T16:59:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/anv-419-anaveon-metastatic-melanoma-likelihood-of-approval/ 2025-01-19T17:17:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/anv-419-anaveon-esophageal-cancer-likelihood-of-approval/ 2025-01-19T17:18:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/4d-710-4d-molecular-therapeutics-cystic-fibrosis-likelihood-of-approval/ 2024-05-20T01:44:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/adrabetadex-mandos-coronary-artery-disease-cad-ischemic-heart-disease-likelihood-of-approval/ 2024-02-21T17:53:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/rlyb-116-rallybio-net-present-value/ 2024-05-16T01:59:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cardiamp-biocardia-net-present-value/ 2024-05-16T02:06:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ap-303-shanghai-alebund-pharmaceuticals-diabetic-nephropathy-likelihood-of-approval/ 2025-01-19T17:01:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nx-1607-nurix-therapeutics-net-present-value/ 2024-06-13T18:48:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/denosumab-biosimilar-celltrion-net-present-value/ 2024-07-02T02:09:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cft-7455-c4-therapeutics-net-present-value/ 2024-06-13T18:53:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/apixaban-taho-pharmaceuticals-pulmonary-embolism-likelihood-of-approval/ 2023-05-30T18:35:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/apixaban-taho-pharmaceuticals-stroke-likelihood-of-approval/ 2023-05-31T17:21:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/abbv-368-abbvie-recurrent-head-and-neck-cancer-squamous-cell-carcinoma-likelihood-of-approval/ 2023-02-24T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/iti-1284-intra-cellular-therapies-net-present-value/ 2024-05-16T01:59:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/kt-333-kymera-therapeutics-net-present-value/ 2024-06-13T18:53:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tyra-300-tyra-biosciences-net-present-value/ 2024-06-13T18:53:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tng-908-tango-therapeutics-net-present-value/ 2024-06-13T18:48:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/rgls-8429-regulus-therapeutics-net-present-value/ 2024-06-13T18:48:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/gsk-4178116a-gsk-net-present-value/ 2024-04-16T16:56:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ard-501-aardvark-therapeutics-autism-spectrum-disorder-asd-likelihood-of-approval/ 2024-02-21T18:12:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/abbv-668-abbvie-net-present-value/ 2024-04-16T17:01:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/vepdegestrant-arvinas-human-epidermal-growth-factor-receptor-2-negative-breast-cancer-her2-breast-cancer-likelihood-of-approval/ 2025-01-19T16:57:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/al-001-alzamend-neuro-alzheimer-s-disease-likelihood-of-approval/ 2023-02-24T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/al-101-alector-alzheimer-s-disease-likelihood-of-approval/ 2024-09-09T01:44:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/carbidopa-levodopa-amneal-pharmaceuticals-parkinson-s-disease-likelihood-of-approval/ 2024-06-19T16:08:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/al-8326-advenchen-laboratories-bladder-cancer-likelihood-of-approval/ 2024-09-09T01:43:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/afimetoran-bristol-myers-squibb-net-present-value/ 2024-06-13T18:52:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/peresolimab-eli-lilly-and-co-net-present-value/ 2024-07-02T02:09:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pegozafermin-89bio-net-present-value/ 2024-05-16T02:05:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/abp-671-jiangsu-atom-bioscience-and-pharmaceutical-gouty-arthritis-gout-likelihood-of-approval/ 2024-09-09T01:47:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/norovirus-strains-norwalk-gi-1-sydney-gii-4-bivalent-vaccine-vaxart-net-present-value/ 2024-06-13T18:53:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/uliledlimab-i-mab-net-present-value/ 2024-07-02T02:04:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ketamine-midazolam-melt-pharmaceuticals-sedation-likelihood-of-approval/ 2024-06-14T01:31:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/the-one-shot-cervical-cancer-vaccine-paradigm/ 2023-02-24T17:26:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/eu-pharma-law-draft/ 2023-02-27T16:40:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/interest-pharma-manufacturers/ 2023-02-24T16:16:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofis-altuviiio-fda-approval-haemophilia-a/ 2023-02-24T16:50:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/colombian-healthcare-reform/ 2023-02-24T12:49:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abbvie-capsida-gene-therapies/ 2023-02-24T10:44:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-kym-biosciences-cmg901/ 2023-02-24T10:29:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/jyseleca-cd-novel-targets/ 2023-05-12T04:43:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovators-ai-in-silico-drug-discovery-pharmaceutical/ 2024-01-05T10:48:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/laronidase-jcr-pharmaceuticals-net-present-value/ 2024-05-16T02:05:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/inz-701-inozyme-pharma-net-present-value/ 2024-05-16T02:05:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/crizanlizumab-novartis-post-essential-thrombocythemia-myelofibrosis-post-et-mf-likelihood-of-approval/ 2023-05-31T18:58:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/satralizumab-f-hoffmann-la-roche-demyelinating-diseases-likelihood-of-approval/ 2025-01-19T16:43:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/seliciclib-cyclacel-pharmaceuticals-rheumatoid-arthritis-likelihood-of-approval/ 2023-02-23T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mrna-3927-moderna-net-present-value/ 2024-05-16T01:58:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/seralutinib-gossamer-bio-pulmonary-arterial-hypertension-likelihood-of-approval/ 2025-01-19T16:52:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/prx-012-prothena-corp-net-present-value/ 2024-06-13T18:52:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/siremadlin-succinate-novartis-acute-myelocytic-leukemia-aml-acute-myeloblastic-leukemia-likelihood-of-approval/ 2025-01-21T16:59:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/dexamethasone-sodium-phosphate-avm-biotechnology-diffuse-large-b-cell-lymphoma-likelihood-of-approval/ 2024-04-20T04:53:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/dexamethasone-sodium-phosphate-avm-biotechnology-primary-mediastinal-b-cell-lymphoma-likelihood-of-approval/ 2024-04-20T04:54:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/dexamethasone-sodium-phosphate-avm-biotechnology-burkitt-lymphoma-likelihood-of-approval/ 2024-04-20T04:54:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/intrachol-protara-therapeutics-net-present-value/ 2024-06-13T18:48:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sisunatovir-hydrochloride-pfizer-respiratory-syncytial-virus-rsv-infections-likelihood-of-approval/ 2025-01-19T16:45:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/docetaxel-nanology-non-muscle-invasive-bladder-cancer-nmibc-superficial-bladder-cancer-likelihood-of-approval/ 2025-01-19T16:57:28+00:00 daily 0.2